In an attempt to bring down out-of-pocket drug costs for Medicare patients, the Centers for Medicare & Medicaid Services has proposed cutting Medicare drug payments to hospitals serving low-income and other disadvantaged communities in the government’s so-called 340B program. But an advocacy group for hospitals and other providers that participate in the program contend that CMS’s proposal would actually backfire and cause those hospitals to serve less patients and provide fewer services.
The 340B program, established by Congress in 1992, requires drug manufacturers to sell certain outpatient drugs at discounts to health care providers that serve low-income and other disadvantaged populations. The providers, in turn, use their 340B drug savings to serve more patients and provide more services at no cost to the government, according to 340B Health, which represents more than 1,300 hospitals and other providers participating in the program.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Katie Kuehner-Hebert
Katie Kuehner-Hebert is a freelance writer based in Running Springs, Calif. She has more than three decades of journalism experience, with particular expertise in employee benefits and other human resource topics.
